Valarmathy Murugaiah

5-methylcytosine (m ⁵ C) RNA modification controls the innate immune response to virus infection by regulating type I interferons

Yuexiu Zhang, Qing Dai, Phylip Chen et al. · Proceedings of the National Academy of Sciences · 2022 · 72 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles

Miao-Hsi Hsieh, Nazar Beirag, Valarmathy Murugaiah et al. · Frontiers in Immunology · 2021 · 60 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Formulation, inflammation, and RNA sensing impact the immunogenicity of self-amplifying RNA vaccines

John S. Tregoning, David C. Stirling, Ziyin Wang et al. · Molecular Therapy — Nucleic Acids · 2022 · 53 citations · Full text

Veterinary Medicine, Biotechnology, Immunology +12

Human C1q Induces Apoptosis in an Ovarian Cancer Cell Line via Tumor Necrosis Factor Pathway

Anuvinder Kaur, Sami Sultan, Valarmathy Murugaiah et al. · Frontiers in Immunology · 2016 · 47 citations · Full text

Life Sciences, Immunology, Oncology +13

Full-length human surfactant protein A inhibits influenza A virus infection of A549 lung epithelial cells: A recombinant form containing neck and lectin domains promotes infectivity

Ahmed A. Al‐Qahtani, Valarmathy Murugaiah, Hani A. Bashir et al. · Immunobiology · 2019 · 44 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17